Sale

Infection Prevention Devices Market

Global Infection Prevention Devices Market Size, Analysis: By Product: Infection Prevention Supplies, Infection Prevention Services, Infection Prevention Equipment; By End User: Hospitals, Lifescience Industries, Clinical Laboratories, Others; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032

Global Infection Prevention Devices Market Outlook

The global infection prevention devices market size was valued at USD 19.31 billion in 2023, driven by the rising need to prevent rather than cure diseases due to the increasing health care costs. The market is anticipated to grow at a CAGR of 5.5% during the forecast period 2024-2032 to reach a value of USD 31.26 billion by 2032.

 

Infection Prevention Devices Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America is the leading market for infection prevention devices due to the growing demand for infection prevention because of the rising surgery rates and patient admissions. The European infection prevention devices market is also expected to grow in the coming years due to the rising geriatric population in the region. With the increasing investments in the industry in countries like China, the industry in the Asia Pacific region is expected to grow at a robust rate in the forecast period.

 

Properties and Applications

Infection prevention devices are equipment or services that help prevent the occurrence of diseases, especially among the at-risk population, like geriatrics, people who have undergone surgeries, or people with a weak immune system.

 

Global Infection Prevention Devices Market By Product

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The infection prevention devices market can be broadly categorised based on its products into:

  • Infection Prevention Supplies
  • Infection Prevention Services
  • Infection Prevention Equipment

Based on end-uses, the industry can be divided into:

  • Hospitals
  • Lifescience Industries
  • Clinical Laboratories
  • Others

The EMR report looks into the regional markets of infection prevention devices like North America, Europe, Latin America, the Asia Pacific, and the Middle East and Africa.

 

Global Infection Prevention Devices Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Market Analysis

The market is being driven by the rising need to prevent rather than cure diseases due to the increasing health care costs. The growing resistance to antibiotics and the slow development of new antibiotics is expected to propel the growth of the industry further. The industry is also supported by the growing rates of hospital admission and outpatient visits.

Infection prevention supplies is expected to be the largest product segment in the market. Based on end-use, hospitals are the largest end-use segment in the industry due to the rising admittance of the geriatric population and the growing research on old age-related diseases.

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global infection prevention devices market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • Medline Industries, LP
  • Cardinal Health 
  • Paul Hartmann AG 
  • Mölnlycke Health Care AB
  • The 3M Company
  • B. Braun Melsungen AG
  • Coloplast Group 
  • Becton, Dickinson and Company
  • Hollister Incorporated
  • Medical Devices Business Services, Inc. (Johnson & Johnson)
  • Others

The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • End User
  • Region
Breakup by Product
  • Infection Prevention Supplies
  • Infection Prevention Services
  • Infection Prevention Equipment
Breakup by End User
  • Hospitals
  • Lifescience Industries
  • Clinical Laboratories
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Medline Industries, LP
  • Cardinal Health
  • Paul Hartmann AG
  • Mölnlycke Health Care AB
  • 3M Company
  • B. Braun Melsungen AG
  • Coloplast Group
  • Becton, Dickinson and Company
  • Hollister Incorporated
  • Medical Devices Business Services, Inc. (Johnson & Johnson)
  • Getinge AB
  • ANSELL LTD
  • BD
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Infection Prevention Devices Market Overview 

    3.1    Global Infection Prevention Devices Market Historical Value (2017-2023) 
    3.2    Global Infection Prevention Devices Market Forecast Value (2024-2032)
4    Global Infection Prevention Devices Market Landscape
    4.1    Global Infection Prevention Devices Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Infection Prevention Devices Product Landscape
        4.2.1    Analysis by Product
        4.2.2    Analysis by End User
5    Global Infection Prevention Devices Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Infection Prevention Devices Market Segmentation
    6.1    Global Infection Prevention Devices Market by Product
        6.1.1    Market Overview                                                                        
        6.1.2    Infection Prevention Supplies
        6.1.3    Infection Prevention Services
        6.1.4    Infection Prevention Equipment
    6.2    Global Infection Prevention Devices Market by End User
        6.2.1    Market Overview
        6.2.2    Hospitals
        6.2.3    Lifescience Industries
        6.2.4    Clinical Laboratories
        6.2.5    Others
    6.3    Global Infection Prevention Devices Market by Region
        6.3.1    Market Overview
        6.3.2    North America 
        6.3.3    Europe
        6.3.4    Asia Pacific
        6.3.5    Latin America
        6.3.6    Middle East and Africa
7    North America Infection Prevention Devices Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Infection Prevention Devices Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Infection Prevention Devices Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Infection Prevention Devices Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Infection Prevention Devices Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Medline Industries, LP
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Cardinal Health
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Paul Hartmann AG
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Mölnlycke Health Care AB
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    3M Company
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    B. Braun Melsungen AG
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Coloplast Group
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Becton, Dickinson and Company
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Hollister Incorporated
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Medical Devices Business Services, Inc. (Johnson & Johnson)
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
    17.11    Getinge AB
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Mergers and Acquisitions
        17.11.5    Certifications
    17.12    ANSELL LTD
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Mergers and Acquisitions
        17.12.5    Certifications
    17.13    BD
        17.13.1    Financial Analysis
        17.13.2    Product Portfolio
        17.13.3    Demographic Reach and Achievements
        17.13.4    Mergers and Acquisitions
        17.13.5    Certifications
18    Global Infection Prevention Devices Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The global infection prevention devices market reached a value of USD 19.31 billion in 2023.

The market is projected to grow at a CAGR of 5.5% during the forecast period of 2024-2032 to reach a value of USD 31.26 billion by 2032.

The increasing incidences of hospital-acquired infections and the rising geriatric population are the major factors driving the growth of this market.

The key trends of the market include rapid advancements in technology, expanding healthcare infrastructure, and the rising personal safety awareness.

The major regions in the infection prevention devices market are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Infection prevention supplies, infection prevention services, and infection prevention equipment are the different products in the market.

Hospitals, lifescience industries, and clinical laboratories, among others, are the various end uses of infection prevention devices in the market.

Infection prevention devices refer to the disposables, consumables, and medical devices that are designed to aid in the prevention or control of infections.

Infections can be spread by the use of infected needles or syringes, unprotected sexual contact, and animal or insect bites.

At-risk populations including people with weakened immune systems, geriatrics, and post-surgery patients are recommended the use of infection prevention devices.

The key players in the global infection prevention devices market are Medline Industries, LP, Cardinal Health, Paul Hartmann AG, Mölnlycke Health Care AB, The 3M Company, B. Braun Melsungen AG, Coloplast Group, Becton, Dickinson and Company, Hollister Incorporated, and Medical Devices Business Services, Inc. (Johnson & Johnson), among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER